Results 91 to 100 of about 5,794,890 (214)

Immunohistochemistry of pulmonary biomarkers a perspective from members of the pulmonary pathology society

, 2017
The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-established and powerful technique. Immunohistochemisty is readily available in pathology laboratories, is relatively easy to perform and assess, can ...
Rekhtman, Natasha, Hariri, Lida P., Natasha Rekhtman, Sylvie Lantuejoul, Dara L. Aisner, Raparia, Kirtee, Teodora Radonic, Ming Sound Tsao, Capelozzi, Vera L., Aisner, Dara L., Lynette M. Sholl, Izidor Kern, Roy-Chowdhuri, Sinchita, Erik Thunnissen, Vera Luiza Capelozzi, Allen, Timothy C., Prudence Russell, Adam, Julien, Mino-Kenudson, Mari, Wendy Cooper, Mari Mino-Kenudson, Schneider, Frank, Allen, Timothy Craig, Ross Miller, Philip T. Cagle, Julien Adam, Frank Schneider, Cooper, Wendy A. (R14282), Cooper, Wendy, Thunnissen, Erik, Lantuejoul, Sylvie, Yatabe, Yasushi, Tsao, Ming Sound, Lida P. Hariri, Sholl, Lynette M., Yasushi Yatabe, Capelozzi, Vera Luiza, Radonic, Teodora, Sinchita Roy-Chowdhuri, Miller, Ross, Beasley, Mary Beth, Borczuk, Alain C., Kern, Izidor, Mary Beth Beasley, Marina Vivero, Alain C. Borczuk, Cagle, Philip T., Vivero, Marina, Kirtee Raparia, Russell, Prudence, Timothy Craig Allen   +50 more
core   +1 more source

Temporomandibular Joint Pathology and Its Indication in Clinical Orthodontics [PDF]

, 2017
Temporomandibular joint (TMJ) pathology has been an area of study in dentistry specifically a research interest in clinical orthodontics in which treatment option has been a dilemma for practitioners.
Ho, KCJ, Rabie, ABM, Li, Q
core   +1 more source

Adversarial attacks and adversarial robustness in computational pathology.

, 2022
Artificial Intelligence (AI) can support diagnostic workflows in oncology by aiding diagnosis and providing biomarkers directly from routine pathology slides. However, AI applications are vulnerable to adversarial attacks.
Han, Tianyu, Buelow, Roman D, van Treeck, Marko, Schulz, Volkmar, Ghaffari Laleh, Narmin, Veldhuizen, Gregory Patrick, Truhn, Daniel, Dislich, Bastian, Boor, Peter, Langer, Rupert, Kather, Jakob Nikolas   +10 more
core   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Clinical and pathological observation of conversion therapy for malignant peritoneal mesothelioma: a case report and literature review

Pathology and Oncology Research
Background: Malignant mesothelioma (MM) is a tumor originating from the pleura, peritoneum, or pericardial cavity. It is divided into diffuse and localized malignant mesothelioma, with four subtypes in diffuse MM: epithelioid, sarcomatoid, desmoplastic ...
Minying Deng, Xinyi Zhang, Chen Xu, Rongkui Luo, Lingli Chen, Yuhong Zhou, Yingyong Hou   +6 more
doaj   +1 more source

Valores de referência do tempo de protrombina (TP) e tempo de tromboplastina parcial ativada (TTPa) em cães Reference ranges of prothrombin time (PT) and activated partial thromboplastin time (aPTT) in dogs

Ciência Rural, 2005
Os fatores de coagulação são parte integrante da hemostasia normal, e tanto as coagulopatias hereditárias como adquiridas que envolvem este sistema são de grande importância veterinária, geralmente evidenciadas por manifestações clínicas, tais como ...
Sonia Terezinha dos Anjos Lopes, Mauren Picada Emanuelli, Claudete Schmidt, Alceu Gaspar Raiser, Alexandre Mazzanti, Aline Souza Alves   +5 more
doaj   +1 more source

The future of speech pathology in aged care: Students’ confidence and interest in working with older people

, 2015
Australia’s demographic future and need for allied health staff equipped to provide services to growing numbers of older people with complex care needs have been documented.
Hewetson, Ronelle, Hunter, Lucy, Cornwell, Petrea, Davern, Susannah, Hill, Anne E.   +4 more
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Selective breast/gynecologic pathology fellowship training in the United States: Experience of program directors [PDF]

Published data on combined breast and gynecologic [breast/gyn] surgical pathology fellowship training programs are limited. Our study aimed to survey the landscape of such fellowships in the United States (US), including specific information about their ...
Bhargava, Rohit, Hagemann, Ian S, Khan, Ashraf, Cosar, Ediz F, Fadare, Oluwole, Jorns, Julie M, Ali, Muhammad, Khoury, Thaer, Desouki, Mohamed Mokhtar, Karabakhtsian, Rouzan G, Klein, Molly E, Clark, Jennifer L, Deavers, Michael T, Pinto, Andre   +13 more
core   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source